View in EDS

The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians.

Saved in:
Bibliographic Details
Title: The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians.
Authors: Subbiah, V.1 vsubbiah@mdanderson.org, Solit, D.B.2,3, Chan, T.A.4, Kurzrock, R.5
Source: Annals of Oncology. Sep2020, Vol. 31 Issue 9, p1115-1118. 4p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152694582
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Subbiah%2C+V%2E%22">Subbiah, V.</searchLink><relatesTo>1</relatesTo><i> vsubbiah@mdanderson.org</i><br /><searchLink fieldCode="AR" term="%22Solit%2C+D%2EB%2E%22">Solit, D.B.</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Chan%2C+T%2EA%2E%22">Chan, T.A.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Kurzrock%2C+R%2E%22">Kurzrock, R.</searchLink><relatesTo>5</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Sep2020, Vol. 31 Issue 9, p1115-1118. 4p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152694582
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2020.07.002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 1115
    Titles:
      – TitleFull: The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Subbiah, V.
      – PersonEntity:
          Name:
            NameFull: Solit, D.B.
      – PersonEntity:
          Name:
            NameFull: Chan, T.A.
      – PersonEntity:
          Name:
            NameFull: Kurzrock, R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1